TH and Parkinson disease: Chronic Δ9‐THCV dosing reduced microglial activation and preserved nigrostriatal dopaminergic neurons after 6‐OHDA application and in the LPS model of Parkinson's disease, Δ9‐THCV preserved TH positive neurons, mirroring the effects of the CB2 receptor agonist HU‐308.